Traws Pharma, Inc. — Director's Dealing 2018

Jan 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2018-01-03

Reporting Person: Guerin Mark Patrick (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-03	Stock Option (right to purchase)	$1.50	A	31024	Acquired	2028-01-03	Common Stock (31024)	Direct

Footnotes

F1: These options vest over three years in 36 equal monthly installments.